Singapore markets close in 7 hours 31 minutes
Straits Times Index
3,298.90 +5.97 (+0.18%) Nikkei
38,236.07 -38.03 (-0.10%) Hang Seng
18,475.92 0.00 (0.00%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
64,317.80 +1,104.55 (+1.75%) CMC Crypto 200
1,337.37 +60.39 (+4.73%)
ABT May 2024 111.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:42PM EDT. Market open.
| Previous close | 5.08 |
| Open | 5.08 |
| Bid | 4.10 |
| Ask | 5.80 |
| Strike | 111.00 |
| Expiry date | 2024-05-31 |
| Day's range | 5.08 - 5.08 |
| Contract range | N/A |
| Volume | |
| Open interest | 10 |
ZacksIs Trending Stock Abbott Laboratories (ABT) a Buy Now?
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
ZacksPBH vs. ABT: Which Stock Is the Better Value Option?
PBH vs. ABT: Which Stock Is the Better Value Option?
PR NewswireAbbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.
© 2024 Yahoo. All rights reserved.